Abstract
Background: Use of herbs and nutritional supplements (known as naturoceuticals) is increasing in the USA, with about 50% of Americans taking naturoceuticals and spending over $10 billion per year for them. This raises concerns regarding their use instead of proven therapies, their side effects, and drug interaction potential.
Hypothesis: The study sought to characterize cardiology patients who used supplements and to examine whether their use was diagnosis or doctor dependent, whether it affected patients' compliance, and what supplements were used.
Methods: In all, 187 patients attending our cardiology clinic were interviewed, examined, and followed for up to 1 year. The users and nonusers of naturoceuticals were compared.
Results: Supplements were used in 106 patients (an average of 3.1 naturoceutical per patient). There were no significant differences in their use by gender, age, primary care doctor specialty, or cardiovascular medications prescribed (except for statins). Patients with a history of myocardial infarction, coronary revascularization, hyperlipidemia, and a family history of coronary artery disease were more likely to use the supplements. Average low‐density lipoprotein (106 vs. 108 mg/dl), average blood pressure (132/77 vs. 138/78 mmHg), and average hemoglobin (Hb)A1c (8.7 vs. 7.7%) showed no statistically significant differences between users and nonusers. Patients most commonly took multivitamins, vitamin E, vitamin C, vitamin B, folate, garlic, calcium, coenzyme Q10, and gingko.
Conclusion: This study indicates that naturoceutical use is widespread among cardiovascular patients and it is difficult to predict clinically who the users are. Fortunately, according to our limited compliance measures, it appears that the naturoceutical use has not affected patients' compliance with traditional medications. Also, possibly a detrimental interaction potential between traditional medications and naturoceuticals has been demonstrated.
Keywords: herbs, supplements, cardiovascular disease, compliance, drug interactions
Full Text
The Full Text of this article is available as a PDF (81.7 KB).
References
- 1. Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, Kessler RC: Trends in alternative medicine use in the United States, 1990–1997: Results of a follow‐up national survey. J Am Med Assoc 1998; 280: 1569–1575 [DOI] [PubMed] [Google Scholar]
- 2. Herbal roulette . Consumer Reports 1995: 698–705
- 3. Dietary Supplement Health and Education Act , 21 USC §343‐2 (1994)
- 4. Nutrition Labeling and Education Act , 21 USC §343‐1 ( 1990)
- 5. Cimons M: House OKs Bill on Vitamin Benefit Claims Health: Measure gives consumers continued access to products but affords government right to oversee nutritional and dietary supplement industry. The Los Angeles Times Oct. 8, 1994;pg. 16
- 6. Foreman J: FDA loosens reigns. Boston Globe January 10, 2000: C1
- 7. Blendon RJ, DesRoches CM, Benson JM, Brodie M, Altman DE: Americans' views on the use and regulation of dietary supplements. Arch Intern Med 2001; 161: 805–810 [DOI] [PubMed] [Google Scholar]
- 8. International Communications Research , survey firm; Harvard School of Public Health and Robert Wood Johnson Foundation, survey sponsors. Storrs, Conn.: Roper Center for Public Opinion Research, April 22, 1999.
- 9. ABC News poll. Storrs, Conn. : Roper Center for Public Opinion Research, January 17, 1997.
- 10. Chilton Research News, survey firm. Storrs, Conn. : Roper Center for Public Opinion Research, February 19, 1999.
- 11. Princeton Survey Research Associates, survey firm; National Public Radio, Henry J. Kaiser Family Foundation, survey sponsors. Storrs, Conn. : Roper Center for Public Opinion Research, December 16–21, 1999.
- 12. International Communications Research, survey firm; Harvard School of Public Health and Henry J. Kaiser Family Foundation, survey sponsors. Storrs, Conn. : Roper Center for Public Opinion Research, December 16–21, 1999.
- 13. Mashour NH, Lin GI, Frishman WH: Herbal medicine for the treatment of cardiovascular disease: Clinical considerations. Arch Intern Med 1998; 158: 2225–2234 [DOI] [PubMed] [Google Scholar]